Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

MAD MONEY FEATURES

Podcasts PODCASTS
Watch the Lightning Round whenever and wherever you want.




Widget OFFICIAL MAD MONEY WIDGET
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.




Soundboard CRAMERS SOUNDBOARD
Admit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.




Mad Money PhotosCHECK OUT OUR PHOTOS
Check out Cramer on set, back to school, behind the scenes and more.




ShopSHOP FOR MAD MERCHANDISE
Buy Cramer books, bobbleheads and other Mad Money merchandise.




Ringtones RING TONES
Pick up the phone! It's Cramer! New Mad Money sounds for your cell phone.




Mobile AlertTEXT MESSAGE ALERT
Mad Money's mobile. Get show highlights sent to your phone.







Text Size

Cramer was “disappointed” with JPMorgan Chase’s equity offering, he said during Tuesday’s Stop Trading!. “A little too much greed” pushed the share price a bit too high, possibly turning off potential buyers.

“They did this one wrong,” Cramer said.

JPMorgan Chase [JPM  Loading...      ()   ] sold shares for $35, a dollar too much as far as the Mad Money host was concerned. If the offering were priced at $34, Cramer said, pointing to the success of SunTrust [STI  Loading...      ()   ], “we would be seeing a major bank rally.”

Cramer also endorsed Huntington Bancshares [HBAN  Loading...      ()   ] as a speculative play on the sector, saying HBAN was a better pick than Fifth Third Bancorp [FITB  Loading...      ()   ] and KeyCorp [KEY  Loading...      ()   ]. Huntington “has made a major turn,” he said.

Strayer Education [STRA  Loading...      ()   ] is leading the school stocks higher, though Cramer prefers Bridgepoint [BPI  Loading...      ()   ]. He called BPI “the overlooked one” of the group, saying it had less exposure to a meddlesome White House and Congress.

Cramer also pointed out that biotech stocks like Genzyme [GENZ  Loading...      ()   ], Celgene [CELG  Loading...      ()   ] and Gilead Sciences [GILD  Loading...      ()   ] were slowly starting to move higher. He thinks these names could edge higher for another two or three days before investors cycle back into iron and steel companies.

“This group has been hammered mercilessly,” Cramer said. “So I don’t think it’s going to be a one-day run.”

















Cramer's charitable trust owns Gilead Sciences and JPMorgan Chase.

Call Cramer: 1-800-743-CBNC

Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?

© 2009 CNBC, Inc. All Rights Reserved

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 02:47:39 10 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:00:35 10 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:56:52 10 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:00:36 10 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters